Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Investigation of risk factors associated with trastuzumab induced cardiotoxicity among HER2 positive breast cancer patients: a Brazilian retrospective study

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: ROCHA AYRES, Lorena (Faculdade de Ciências Farmacêuticas de Ribeirão Preto - FCFRP/USP, Ciências Farmacêuticas, Ribeirão Preto, Brazil)
  • Co-author(s): Silveira de Almeida Campos, Marília (Faculdade de Ciências Farmacêuticas de Ribeirão Preto - FCFRP/USP, Ribeirão Preto, Brazil)
    De Oliveira Gozzo, Thais (Escola de Enfermagem de Ribeirão Preto - Universidade de São Paulo - EERP/USP, Ribeirão Preto, Brazil)
    Ungari, Andrea (Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - HCFMRP/USP, Ribeirão Preto, Brazil)
    Moreira de Andrade, Jurandyr (Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - HCFMRP/USP, Ribeirão Preto, Brazil)
    Régis Leira Pereira, Leonardo (Faculdade de Ciências Farmacêuticas de Ribeirão Preto - FCFRP/USP, Ribeirão Preto, Brazil)
  • Abstract:


    Background


    :

    The monoclonal antibody trastuzumab improves survival in HER2 positive breast cancer patients. However, it is related to an elevated incidence of cardiotoxicity.
    Aim:

    In order to identify risk factors associated with trastuzumab induced cardiotoxicity (TIC), this study investigated data from breast cancer patients in a routine clinical


    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses